Top Tweets for #CVDeath
#VICTOR #ESCCongress #LBCT
🫀Vericiguat in Chronic #HFrEF
🫀population:1/2 no prior HF hospitalization, excellent GDMT
🫀 Nonetheless, no significant finding of difference of Vericiguat 🆚 Placebo
🫀did ⤵️ risk of CV death
#VICTOR & #VICTORIA pooled analysis by Prof @JavedButler1 at #ESCCongress #LBCT
📍 >11,000 pts with chronic #HFrEF
📍#Vericiguat ⬇️ risk of all-cause death, #CVdeath & #HHF across broad spectrum of disease
📍Benefit most notable in pts with NT-proBNP ≤6000 pg/mL
📍Well tolerated, favorable safety profile
@escardio #HeartFailure #GDMtTworks
#VICTOR results from #ESCCongress #LBCT presented by @FaiezZANNAD
📍#Vericiguat did NOT ⬇️ #CVdeath or #HHF in ambulatory #HFrEF on #GDMT
📍Secondary analysis: significant ⬇️ #CVdeath
📍Favorable effects in compensated #HFrEF outpatients
@escardio @JavedButler1
🔥DAPA ACT HF-TIMI 68 trial results
Fresh from #ESCCongress
📍No significant ⬇️ in #CVdeath or worsening HF at 2 months with in-hospital #Dapagliflozin
⚠️But‼️
📍 Meta-analysis with other RCTs: early in-hospital #SGLT2i initiation ⬇️ adverse outcomes including #CVdeath & all-cause mortality post-discharge
📍Safe & well-tolerated, consistent with SGLT2i class profile
@escardio @ddbergMD @TIMIStudyGroup @CVR_TomaszGuzik @jozinetm #GDMTworks
Elevated IL-6 & hs-CRP levels = higher risk of worsening HF or #cvDeath in #HFrEF patients, based on DAPA-HF study.
✅ However, #dapagliflozin reduced outcomes regardless of baseline inflammation
📎https://t.co/AAQtJovnUi
#JACCHF #HeartFailure @scottdsolomon
"Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath"
#EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath
Read our recently published evidence-based statement, which reinforces our ongoing commitment to science-driven public health, at a time when misinformation is putting lives at risk https://t.co/l6Fy1pFVVw
Link to the press release: https://t.co/VVT1L0Mivj
#HFA_ESC #EAPC_ESC #ACVC_ESC #COVID19 #infection #influenza #pneumococcus
#EHJ: Consensus document on vaccination as CV prevention Vaccination is not only vital for preventing infectious diseases, it is also a proven strategy to reduce the risk of heart attacks, #heartfailure, and premature #cvdeath
Read our recently published evidence-based statement, which reinforces our ongoing commitment to science-driven public health, at a time when misinformation is putting lives at risk https://t.co/l6Fy1pFVVw
Link to the press release: https://t.co/VVT1L0Mivj
#HFA_ESC #EAPC_ESC #ACVC_ESC #COVID19 #infection #influenza #pneumococcus
📌 Do you know that #cannabis use
🔊 assoc. w/ ⬆️ risk of
🔹🧠 #Stroke 👉 RR=1.20
🔹❤️🔥 #AcuteCoronarySyndrome 👉 RR=1.29
🔹☠️ #CVdeath 👉 RR=2.10 ❗️
#CardioTwitter #MedTwitter #medstudent #Review @DrMarthaGulati @AnastasiaSMihai @cpgale3 @mmamas1973 @SeguraCardio @Hragy @iamritu
HELIOS-B: #Vutrisiran reduces all-cause mortality, presented by @MariannaFonta11
📍 Significant reduction in all-cause & #CVdeath ☠️ over 42 months vs placebo
📍 Lower rates of #CVevents and #HF hospitalisations 🏥 over 36 months vs placebo
#ATTR #cardiacamyloidosis
#HeartFailure2025 #HFA_ESC
@escardio
#FINE_HEART: #Finerenone in #CKD and #T2DM
Pooled analysis from #FINEARTS_HF, #FIDELIO_DKD #FIGARO_DKD
📍18.991 pts, median 2.9 years
📍#CVdeath: ⬇️ 11%
📍All-cause death: ⬇️ 9%
📍#HeartFailure Hospitalizations: ⬇️17%
📍#Kidney ⬆️ 20%
#ESCCongress
#FINEARTS_HF LIVE from #ESCCongress:
📍The first-ever trial of #MRA in #HFpEF / #HFmrEF to hit its primary endpoint! 🎯
#Finerenone:
📍16% reduction in the primary endpoint 🔥
📍Absolute risk reduction of 3.3/100 patient-years for #CVdeath and total #WHF 💪
📍Improved symptoms, safe, and well tolerated🌟
#Cardiology #HeartFailure #FunctionNotFailure
@scottdsolomon @WilfriedMullens
🚨‼️#ESCCongress 2024 🇬🇧
HOTLINE: #FINEARTSHF study just released by Scott Solomon 😵
👉🏼Finerenone versus placebo among patients with HFmrEF and HFpEF
🎯FINEARTS-HF met its primary endpoint: ⬇️ 16% CV death and total HF events
🏅Another game changer for HFpEF!!
@escardio
🔴 Contemporary Use & Implications of Beta-Blockers in Ptsw/ HFmrEF or HFpEF: The DELIVER Trial
✅BB use wasn't linked to #worseningHF or #cvDeath. Benefits of #dapa remained regardless of BBs, reassuring their role in Rx HFpEF/ HFmrEF alongside #SGLT2i. https://t.co/LX768Ji1gc
#BetaBlocker use in #HFpEF and #HFmrEF❓
In this month’s issue of #JACCHF, analysis of #DELIVER trial shows:
♥️ 4 out of 5 px were treated with #BB
♥️#BB use wasn't linked to #worseningHF or #CVdeath
♥️Benefits of #Dapagliflozin remained consistent regardless of #BB
➡️➡️ reassuring for background #BB use in #HFpEF / #HFmrEF alongside #SGLT2i
🔗: https://t.co/lANbPOtjE0
Analysis of #DELIVER trial shows that beta-blocker use wasn't linked to #worseningHF or #cvDeath. Benefits of #dapagliflozin remained consistent regardless of beta-blockers, reassuring their role in treating #HFpEF or #HFmrEF alongside #SGLT2i. https://t.co/PmHo26MDOq #JACCHF
Moderate/severe TR raises #HeartFailure & #CVdeath risk in #HFrEF patients, highlighting the need for TR management. This study also shows that omecamtiv mecarbil’s effectiveness remains unaffected by TR severity. https://t.co/CTw0YXNAxV
#JACCHF @MariannaAdamo1 @MarcoMetra
Relationship between #TricuspidRegurgitation x #HFrEF❓
🫀Moderate/severe TR ⬆️ risk of HF events& #CVdeath, highlighting the importance of managing TR in HF‼️
🫀Omecamtiv mecarbil was effective regardless of TR severity
More 🖇️: https://t.co/qTIbkT1jt3 #JACCHF #GALACTICHF
Sotagliflozin reduces relative risk of hospital readmissions for #HeartFailure by 53% & composite of #CVdeath or #HF readmission by 52% within 30 days of discharge. https://t.co/W7xcmWB0yL
#JACCHF #SOLOISTWHF #SGLT2i #Sotagliflozin #CardioTwitter #GDMT #cardioEd #Cardiology
#FINALITY-HF will evaluate #FINERENONE vs #PLACEBO in 2,600 #HFrEF patients not on #sMRA on #CVDeath and #HF Events. #MOONRAKER @MkosiborodMD @BayerPharma @MarcBonaca @cpcannon @AndrewJSauer @anita_deswal @EriKato71362632 @MicheleSenni @HeerspinkHiddo https://t.co/QE27uFTNDr
#REDEFINE-HF (NCT06008197) will assess #FINERENONE vs #PLACEBO in 5,200 acute #HFmrEF or #HFpEF patients on #CVDeath & #HF Events. #MOONRAKER @MkosiborodMD @BayerPharma @MarcBonaca @cpcannon @AndrewJSauer @JavedButler1 @lamcardio @scottdsolomon @KSharmaMD https://t.co/QE27uFUlsZ
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.2M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.2M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers